HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

LEE PHARMACEUTICALS FIRST QUARTER SALES DROP 29.9%

This article was originally published in The Rose Sheet

Executive Summary

LEE PHARMACEUTICALS FIRST QUARTER SALES DROP 29.9% to $2.4 mil. for the period ended Dec. 31 due to retailers' lower inventory levels, the company reported recently. However, Lee said, the decline "was partially offset by sales of newly acquired brands" such as ThexForte vitamins, Creo-Terpin liquid cough suppressant, Tear-Gard eye lubricant, Iodex anti-infective ointments, Dr. Hand's teething products and Dentlock denture adhesive brands, purchased from Medtech Labs last spring ("The Rose Sheet," May 24, p. 3). Lee also acquired Sundance aloe products in September and Saxon cream aftershaves in October.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

RS000191

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel